In head and neck cancer, the inhibition of CD147 alleviates proinflammatory cytokines, e.g., IL-1β, IL-6, and IL-8, mediated cancer cell proliferation in vitro and in vivo [16]. Here, CXCL8 is linked to head and neck cancer.